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4.  Exotoxins
-Streptolisyn O (SLO)
-Streptolisyn S (SLS)
- STSS exotoxins superantigens
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MOLECULAR BASIS OF PATHOGENIA
First, it was thought that these bacteria were extracellular but finally was discovered that they could enter to host cell and stay
there. S. pyogenes firstly adhere to different epithelial cells, and subsequently occurs the internalization. The bacteria can also
disseminate to secure regions and persistence with different mechanisms. There are also extracellular products contributing
to streptococcal pathogenia, the exotoxins.
For each step there are important molecules, essential for the appearance of the illness. Some of them are shown below.
1. Adhesion
Different adhesins to attach at the host cell:
-Hialuronic acid Capsule (HA)
- Lipoteichoic acid (LTA)
- Pili
- Protein M  emm gene 
- Fibronectin-binding protein
Some of them have antifagocitary ability (HA, M 
protein)
2.   Internalization
Most important invasins for enter to 
host cells:
- SfbI/F1
- Protein M
CONCLUSIONS
Through the entirely project we can observe that
the capability of the bacteria to adhere and the
internalization in secure zones, avoid the host
immune system and antibiotic treatment. Together
with the ability to invade PMNs and disseminate
through the human body makes this pathogen so
versatile and not easy to eradicate.
The use of penicillin not eliminates the intracellular
bacteria so fail in completely eradication. Instead
of that, macrolides have this capability, but there is
an important problem, the emerging resistances.
Because of all that, is necessarily an extensive
study to find out how avoid this persistence and
dissemination to prevent this acute infections. Also
it’s important to find out new targets to attack the
bacteria and finally eradicate this pathogen
efficiently.
3.   Dissemination and 
persistence
Production of acute and recurrent infections.
Dissemination:
-Troya horse theory, secure dissemination 
Persistence:
-Hide in extracellular matrix 
-Remain in cytoplasm or intracellular 
compartment 
Figure 1. Clincal of S. pyogenes
ANTIBIOTIC RESISTANCE
Now a days, the treatment is based on the use of antibiotics to
eliminate the bacteria. The most habitual used are penicillin, but
also have been used macrolides, like erythromycin. S. pyogenes is
still susceptible to penicillin but not for macrolides, there have
been notified resistant strains for it. There are two mechanisms
for its resistance:
-Alteration of target site: modification of rRNA 23S, avoiding the
action of the antibiotic.
-Efflux pump: through this mechanism the antibiotic is expulsed
outside.
There are more resistances to other antibiotics, like tetracycline
but not with the same percentage, so the most important are the
macrolides.
Besides, have been reported the appearance of tolerant strains to
penicillin, is not the same as the previous resistances. These
strains maintain quiescent until penicillin is retired, this occurs
due to stk gene.
Macrolides
Susceptible
- β-lactams  Penicillin
Resistance
- Macrolides  Erythromycin        32.8 %
- Tetracyclines Tetracycline 6.8 %
- Lincodamides  Clindamycin 6.5 % 
Figure 2. Mechanisms of antibiotic resistance
INTRODUCTION
Streptococcus pyogenes is a grampositive human pathogen with a high clinical, been able to cause acute infections. It is
named as Group A Streptococcus (GAS) because it has the serogroup A carbohydrates, besides produces β-hemolysis in blood
agar medium.
In 2005, the estimated number of people suffering from a serious GAS disease was approximately 18,1 million, with a further
1,78 million new cases occurring each year, accounting for 517.000 deaths annually. The real burden of GAS is
underestimated because it isn’t universally notifiable, so this data are not entirely real. The majority of deaths are attributable
to RHD and its complications, followed by invasive group A streptococcal diseases (iGAS), then acute post-streptococcal
glomerulonephritis (ASPGN). Also contributing to morbidity and healthcare expenditure is the highly prevalent condition of
pharingitis and tonsillitis. In figure 1 are shown the different symptoms that can produce the bacteria.
The objective is to determine what is currently known about the mechanisms of S. pyogenes for infect the human and it has
been analyzed the importance of the emerge of antibiotic resistance in this pathogen.
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